Diaphorina citri psyllid: psy558

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690--
FTSPAVKKLLGWKQGDEEEKWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVLPPIVVPRHSEFAPGHSLLPYQQMAEPTMPHNISYSNNGFNQPHSPLSSVSSPASSNNPHSPYQSNGLPGKAQFNFEILSNFNYLVSTETPPPAYSPPQDEKHGSQSPHSENAMDTGISSDVTPVPYQVTYFELLTCLMPKMNPNFEEYPTTHIIKMNLYSSFSPPQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFAELLSQSVNHGFEAVYELTKMCTISPIFCIRNKCNRTEIPFAVKVPRQFSLSVIILWYFVLISRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLIQMGSPHQPISSVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVTLFDILTHLKIYSFYFLPVLPPIVVPRHSEFAPGHSLLPYQQMAEPTMPHNISYSNNGFNQPHSPLSSVSSPASSNNPHSPYQSNGLPGEKCVKHKCLSQMLFPA
ccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHccccHHHHHHHHccccccccEEEEcccccccccccccccccEEEEEEEEcccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEccccEEccCEEcccccEEEEcccccccccccccccccccccccHHHHHHHccccccEEEEEEccEEEEEEcccccEEEcccccccccccccccCEEccccccEEEEcHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEHHcEEEEEEEEEECccccccccccccccccccHHHcccHHHHHHHHHHcccccccccccccccccccEEEEEEEEccccccccccccccccccccccccccCEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
**SPAVKKLLGWKQ*****KWAEKAVDSLVKKLKKSKGDIEELERALSCPGQPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVLPPIVVPRHS*F**********************************************************************************************************************YFELL********PNFEEYPTTHIIKMNLYSSFSPPQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFAELLSQSVNHGFEAVYELTKMCTISPIFCIRNKCNRTEIPFAVKVPRQFSLSVIILWYFVLISRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLIQMGSPH**ISSVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVTLFDILTHL***SFYFLPVLPPIVVPRHSEFAP************************************************************************
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
FTSPAVKKLLGWKQGDEEEKWAEKAxxxxxxxxxxxxxxxxxxxxxLSCPGQPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVLPPIVVPRHSEFAPGHSLLPYQQMAEPTMPHNISYSNNGFNQPHSPLSSVSSPASSNNPHSPYQSNGLPGKAQFNFEILSNFNYLVSTETPPPAYSPPQDEKHGSQSPHSENAMDTGISSDVTPVPYQVTYFELLTCLMPKMNPNFEEYPTTHIIKMNLYSSFSPPQEQPFWASIAYYELNSRVGEVFHCQSHSVIVDGFTNPSNNLNRFCLGQLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSAIFVQSRNCNHHHGFHQSTVCKIPAGCSLKIFNNQEFAELLSQSVNHGFEAVYELTKMCTISPIFCIRNKCNRTEIPFAVKVPRQFSLSVIILWYFVLISRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLIQMGSPHQPISSVSHRKGLPHVIYCRVWRWPDLQSHHELKPLEHCQFPFSAKQKDVCINPYHYKRVESPVTLFDILTHLKIYSFYFLPVLPPIVVPRHSEFAPGHSLLPYQQMAEPTMPHNISYSNNGFNQPHSPLSSVSSPASSNNPHSPYQSNGLPGEKCVKHKCLSQMLFPA

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Mothers against decapentaplegic homolog 1 Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1.confidentQ15797
Mothers against decapentaplegic homolog 1 Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD).confidentQ1JQA2
Mothers against decapentaplegic homolog 5 Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD).confidentQ5R6H7

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0003700 [MF]sequence-specific DNA binding transcription factor activityprobableGO:0003674, GO:0001071
GO:0001666 [BP]response to hypoxiaprobableGO:0009628, GO:0036293, GO:0050896, GO:0006950, GO:0008150, GO:0070482
GO:0051496 [BP]positive regulation of stress fiber assemblyprobableGO:0051130, GO:0032231, GO:0032233, GO:0033043, GO:0051493, GO:0051495, GO:0032970, GO:0010638, GO:0051492, GO:0050794, GO:0044087, GO:0065007, GO:0032956, GO:0048518, GO:0008150, GO:0051128, GO:0050789, GO:0048522
GO:0000988 [MF]protein binding transcription factor activityprobableGO:0003674
GO:0007281 [BP]germ cell developmentprobableGO:0032502, GO:0044702, GO:0048609, GO:0032504, GO:0022414, GO:0048869, GO:0032501, GO:0030154, GO:0048468, GO:0019953, GO:0044767, GO:0003006, GO:0048610, GO:0044763, GO:0044699, GO:0022412, GO:0008150, GO:0009987, GO:0000003, GO:0007276, GO:0048856
GO:0001756 [BP]somitogenesisprobableGO:0032502, GO:0007389, GO:0044699, GO:0032501, GO:0009952, GO:0044707, GO:0048856, GO:0007275, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0003002, GO:0043009, GO:0009653, GO:0035282, GO:0048646, GO:0061053
GO:0000979 [MF]RNA polymerase II core promoter sequence-specific DNA bindingprobableGO:0044212, GO:0003676, GO:0043565, GO:0001067, GO:0000975, GO:0001012, GO:0000976, GO:0000977, GO:0001047, GO:0001046, GO:0003674, GO:0097159, GO:0003677, GO:1901363, GO:0005488
GO:0007492 [BP]endoderm developmentprobableGO:0032502, GO:0048856, GO:0008150, GO:0009888
GO:0031490 [MF]chromatin DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0042177 [BP]negative regulation of protein catabolic processprobableGO:0051248, GO:0009895, GO:0010605, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0009894, GO:0008150, GO:0042176, GO:0065007, GO:0048519, GO:0009892, GO:0050789
GO:0032444 [CC]activin responsive factor complexprobableGO:0031974, GO:0043229, GO:0043227, GO:0043226, GO:0005575, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0005667, GO:0044424, GO:0044422
GO:0008285 [BP]negative regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0001657 [BP]ureteric bud developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0001655, GO:0048731, GO:0035295, GO:0072001, GO:0007275, GO:0044699
GO:0060021 [BP]palate developmentprobableGO:0032502, GO:0048856, GO:0008150
GO:0002051 [BP]osteoblast fate commitmentprobableGO:0032502, GO:0045165, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0001503, GO:0044763, GO:0044699, GO:0008150, GO:0009987, GO:0001649
GO:0010718 [BP]positive regulation of epithelial to mesenchymal transitionprobableGO:0022604, GO:2000736, GO:0022603, GO:0051128, GO:0050789, GO:0060284, GO:0010769, GO:0065007, GO:0010720, GO:0048518, GO:0051130, GO:0050793, GO:0050794, GO:0045597, GO:0045595, GO:0008150, GO:0051239, GO:0051094, GO:0010717, GO:2000026, GO:0010770, GO:0048522
GO:0019049 [BP]evasion or tolerance of host defenses by virusprobableGO:0019048, GO:0052200, GO:0075136, GO:0000003, GO:0044419, GO:0044413, GO:0051832, GO:0044415, GO:0051834, GO:0009987, GO:0052173, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0051701, GO:0051707, GO:0051704, GO:0044703, GO:0009607, GO:0050896, GO:0016032, GO:0044403
GO:0060348 [BP]bone developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0001501, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001880 [BP]Mullerian duct regressionprobableGO:0032502, GO:0007548, GO:0032501, GO:0000003, GO:0044707, GO:0022414, GO:0048856, GO:0060033, GO:0007275, GO:0044767, GO:0003006, GO:0008150, GO:0009653, GO:0046661, GO:0044699
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0006468 [BP]protein phosphorylationprobableGO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0040011 [BP]locomotionprobableGO:0008150
GO:0045669 [BP]positive regulation of osteoblast differentiationprobableGO:0051094, GO:0050793, GO:0045595, GO:0050794, GO:0045597, GO:0045667, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0030278, GO:0050789, GO:0048522
GO:0016202 [BP]regulation of striated muscle tissue developmentprobableGO:1901861, GO:0050793, GO:0048634, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0050789
GO:0030218 [BP]erythrocyte differentiationprobableGO:0030154, GO:0042592, GO:0007275, GO:0044699, GO:0048869, GO:0002262, GO:0008150, GO:0048513, GO:0065007, GO:0048534, GO:0065008, GO:0032502, GO:0034101, GO:0032501, GO:0009987, GO:0044767, GO:0044763, GO:0030097, GO:0002520, GO:0048872, GO:0044707, GO:0048856, GO:0002376, GO:0030099, GO:0048731
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0010243 [BP]response to organic nitrogenprobableGO:0009719, GO:0050896, GO:1901698, GO:0008150, GO:0042221, GO:0010033
GO:0048589 [BP]developmental growthprobableGO:0044767, GO:0032502, GO:0008150, GO:0040007, GO:0044699
GO:0007183 [BP]SMAD protein complex assemblyprobableGO:0022607, GO:0070271, GO:0043933, GO:0007167, GO:0023052, GO:0007165, GO:0007166, GO:0034622, GO:0050789, GO:0044699, GO:0051716, GO:0071822, GO:0016043, GO:0065003, GO:0065007, GO:0071840, GO:0009987, GO:0006461, GO:0050794, GO:0044763, GO:0007154, GO:0043623, GO:0007178, GO:0044700, GO:0050896, GO:0044085, GO:0008150
GO:0009887 [BP]organ morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0009880 [BP]embryonic pattern specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0007275, GO:0044699
GO:0031625 [MF]ubiquitin protein ligase bindingprobableGO:0003674, GO:0044389, GO:0005515, GO:0019899, GO:0005488
GO:0060290 [BP]transdifferentiationprobableGO:0032502, GO:0030154, GO:0048869, GO:0009987, GO:0044763, GO:0008150, GO:0044699
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0005518 [MF]collagen bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0010694 [BP]positive regulation of alkaline phosphatase activityprobableGO:0051336, GO:0019220, GO:0019222, GO:0051345, GO:0010921, GO:0010922, GO:0050790, GO:0031323, GO:0050789, GO:0051174, GO:0065007, GO:0044093, GO:0010692, GO:0008150, GO:0035303, GO:0050794, GO:0065009, GO:0043085
GO:0051894 [BP]positive regulation of focal adhesion assemblyprobableGO:0051130, GO:1901888, GO:1901890, GO:0010811, GO:0030155, GO:0001954, GO:0001952, GO:0090109, GO:0008150, GO:0044087, GO:0010810, GO:0048518, GO:0051893, GO:0065007, GO:0045785, GO:0051128, GO:0050789, GO:0050794, GO:0048522
GO:0030501 [BP]positive regulation of bone mineralizationprobableGO:0070169, GO:0045778, GO:0050793, GO:0051240, GO:0051094, GO:0070167, GO:0008150, GO:0048518, GO:2000026, GO:0051239, GO:0030500, GO:0065007, GO:0030278, GO:0050789
GO:0061036 [BP]positive regulation of cartilage developmentprobableGO:0051094, GO:0050793, GO:0008150, GO:0061035, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0019901 [MF]protein kinase bindingprobableGO:0019900, GO:0003674, GO:0005515, GO:0019899, GO:0005488
GO:0007179 [BP]transforming growth factor beta receptor signaling pathwayprobableGO:0007166, GO:0023052, GO:0007165, GO:0070887, GO:0007167, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0070848, GO:0071310, GO:0065007, GO:0071559, GO:0071495, GO:0009987, GO:0050794, GO:0042221, GO:0044763, GO:0007154, GO:0010033, GO:0007178, GO:0044700, GO:0071363, GO:0050896, GO:0071560, GO:0008150
GO:0030618 [MF]transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activityprobableGO:0005057, GO:0005072, GO:0003674, GO:0004871, GO:0060089
GO:0060395 [BP]SMAD protein signal transductionprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0030616 [MF]transforming growth factor beta receptor, common-partner cytoplasmic mediator activityprobableGO:0005057, GO:0005072, GO:0003674, GO:0004871, GO:0060089
GO:0060038 [BP]cardiac muscle cell proliferationprobableGO:0055017, GO:0072359, GO:0072358, GO:0035265, GO:0007275, GO:0044699, GO:0040007, GO:0033002, GO:0048513, GO:0032502, GO:0032501, GO:0008283, GO:0009888, GO:0044767, GO:0008150, GO:0007507, GO:0044707, GO:0048856, GO:0014706, GO:0048738, GO:0060419, GO:0060537, GO:0048731, GO:0014855
GO:0032924 [BP]activin receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0006810 [BP]transportprobableGO:0051234, GO:0008150, GO:0051179
GO:0006954 [BP]inflammatory responseprobableGO:0006952, GO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0048732 [BP]gland developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0030509 [BP]BMP signaling pathwayprobableGO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0050789, GO:0044699, GO:0051716, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0010468, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0044763, GO:0051171, GO:2001141, GO:0007154, GO:0007178, GO:0044700, GO:0050896, GO:0051252, GO:0006355, GO:0010556, GO:0008150
GO:0006351 [BP]transcription, DNA-dependentprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0019438
GO:0060048 [BP]cardiac muscle contractionprobableGO:0032501, GO:0044707, GO:0006936, GO:0008015, GO:0006941, GO:0003012, GO:0060047, GO:0008150, GO:0003015, GO:0003013, GO:0044699, GO:0003008
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0005637 [CC]nuclear inner membraneprobableGO:0005575, GO:0016020, GO:0031090, GO:0005623, GO:0031965, GO:0005634, GO:0005635, GO:0019866, GO:0031967, GO:0005622, GO:0044446, GO:0043229, GO:0044428, GO:0012505, GO:0044424, GO:0044464, GO:0031975, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0060562 [BP]epithelial tube morphogenesisprobableGO:0032502, GO:0002009, GO:0048856, GO:0035239, GO:0044707, GO:0060429, GO:0009888, GO:0044767, GO:0032501, GO:0008150, GO:0048729, GO:0035295, GO:0009653, GO:0007275, GO:0044699
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0050775 [BP]positive regulation of dendrite morphogenesisprobableGO:0022604, GO:0032502, GO:0044707, GO:0051239, GO:0022603, GO:0030154, GO:0051128, GO:0031344, GO:0044699, GO:0031346, GO:0050767, GO:0048869, GO:0060284, GO:0050769, GO:0045664, GO:0010769, GO:0065007, GO:0010720, GO:0048518, GO:0051130, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045597, GO:0045595, GO:0008150, GO:0010975, GO:0022008, GO:0048699, GO:0007399, GO:0050773, GO:0051094, GO:0048856, GO:0044763, GO:0050789, GO:0051960, GO:2000026, GO:0048814, GO:0007275, GO:0048731, GO:0048522
GO:0071407 [BP]cellular response to organic cyclic compoundprobableGO:0051716, GO:0050896, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0044699, GO:0070887, GO:0042221, GO:0010033, GO:0014070
GO:0000165 [BP]MAPK cascadeprobableGO:0044700, GO:0051716, GO:0007243, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0050789, GO:0044699
GO:0006919 [BP]activation of cysteine-type endopeptidase activity involved in apoptotic processprobableGO:0019222, GO:2001056, GO:0007569, GO:0010941, GO:0042981, GO:0050789, GO:0043085, GO:0097202, GO:0051345, GO:2000116, GO:0043067, GO:0065007, GO:0044699, GO:0044093, GO:0043281, GO:0043280, GO:0065009, GO:0010259, GO:0009987, GO:0052547, GO:0052548, GO:0006915, GO:0050794, GO:0012501, GO:0044763, GO:0010950, GO:0010952, GO:0051336, GO:0050790, GO:0008150
GO:0030901 [BP]midbrain developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0030902 [BP]hindbrain developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0050927 [BP]positive regulation of positive chemotaxisprobableGO:0040012, GO:0032103, GO:0040017, GO:0032101, GO:0048584, GO:0048583, GO:0050795, GO:0050789, GO:0008150, GO:0050926, GO:0050920, GO:0050921, GO:0048518, GO:0065007, GO:0048520
GO:0010608 [BP]posttranscriptional regulation of gene expressionprobableGO:0019222, GO:0060255, GO:0050789, GO:0008150, GO:0065007, GO:0010468
GO:0042993 [BP]positive regulation of transcription factor import into nucleusprobableGO:0033157, GO:0032388, GO:0060341, GO:0051049, GO:0032386, GO:0051222, GO:0051223, GO:0050789, GO:0032880, GO:0065007, GO:0048518, GO:0070201, GO:0051050, GO:0090316, GO:0050794, GO:0008150, GO:0042307, GO:0042306, GO:0032879, GO:0042990, GO:1900180, GO:0046824, GO:0046822
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0030511 [BP]positive regulation of transforming growth factor beta receptor signaling pathwayprobableGO:0090287, GO:0090100, GO:0009966, GO:0009967, GO:0048584, GO:0017015, GO:0090092, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0030510 [BP]regulation of BMP signaling pathwayprobableGO:0090092, GO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0050789
GO:0051216 [BP]cartilage developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0009888, GO:0061448, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001822 [BP]kidney developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0001655, GO:0048731, GO:0072001, GO:0007275, GO:0044699
GO:0043130 [MF]ubiquitin bindingprobableGO:0003674, GO:0032182, GO:0005488, GO:0005515
GO:0000987 [MF]core promoter proximal region sequence-specific DNA bindingprobableGO:0044212, GO:0043565, GO:0097159, GO:0000975, GO:0001067, GO:0001159, GO:0000976, GO:0005488, GO:0003676, GO:0003677, GO:0003674, GO:1901363
GO:0042060 [BP]wound healingprobableGO:0050896, GO:0006950, GO:0008150, GO:0009611
GO:0030308 [BP]negative regulation of cell growthprobableGO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0045892 [BP]negative regulation of transcription, DNA-dependentprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0003690 [MF]double-stranded DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0001710 [BP]mesodermal cell fate commitmentprobableGO:0048598, GO:0007498, GO:0030154, GO:0009790, GO:0009653, GO:0007275, GO:0044699, GO:0001707, GO:0001704, GO:0048869, GO:0007369, GO:0048729, GO:0048646, GO:0032502, GO:0032501, GO:0048332, GO:0048333, GO:0009987, GO:0009888, GO:0044767, GO:0044763, GO:0045165, GO:0044707, GO:0048856, GO:0060795, GO:0008150
GO:0051098 [BP]regulation of bindingprobableGO:0008150, GO:0065009, GO:0065007
GO:0071141 [CC]SMAD protein complexprobableGO:0043234, GO:0032991, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0032909 [BP]regulation of transforming growth factor beta2 productionprobableGO:0050789, GO:0001817, GO:0008150, GO:0051239, GO:0065007, GO:0071634
GO:0070412 [MF]R-SMAD bindingprobableGO:0046332, GO:0003674, GO:0005488, GO:0005515
GO:0070410 [MF]co-SMAD bindingprobableGO:0046332, GO:0003674, GO:0005488, GO:0005515
GO:0070411 [MF]I-SMAD bindingprobableGO:0046332, GO:0003674, GO:0005488, GO:0005515
GO:0008270 [MF]zinc ion bindingprobableGO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0005886 [CC]plasma membraneprobableGO:0005575, GO:0044464, GO:0016020, GO:0071944, GO:0005623
GO:0001932 [BP]regulation of protein phosphorylationprobableGO:0042325, GO:0032268, GO:0019220, GO:0080090, GO:0019222, GO:0060255, GO:0031323, GO:0051246, GO:0050794, GO:0051174, GO:0065007, GO:0031399, GO:0008150, GO:0050789

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3KMP, chain A
Confidence level:very confident
Coverage over the Query: 1-124
View the alignment between query and template
View the model in PyMOL
Template: 3GMJ, chain D
Confidence level:very confident
Coverage over the Query: 294-439,479-531
View the alignment between query and template
View the model in PyMOL
Template: 1DD1, chain A
Confidence level:very confident
Coverage over the Query: 279-422,453-522
View the alignment between query and template
View the model in PyMOL
Template: 1OZJ, chain A
Confidence level:very confident
Coverage over the Query: 508-585
View the alignment between query and template
View the model in PyMOL